Virtu Financial’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Virtu Financial’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65,416	Closed	-$275K	–	2464
2022 Q2	$275K	Buy	65,416 +51,489	+370%	+$204K	0.02%	618
2022 Q1	$47K	Buy	+13,927	New	+$44.1K	﹤0.01%	1157
2019 Q4	–	Sell	-11,722	Closed	-$69K	–	1973
2019 Q3	$69K	Buy	+11,722	New	+$124K	0.01%	1147
2019 Q2	–	Sell	-11,839	Closed	-$143K	–	1991
2019 Q1	$143K	Buy	+11,839	New	+$174K	0.01%	1073

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial's CNCE Position: Q3 2022 in Review

Virtu Financial sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2022, closing a stake of 65,416 shares — an estimated $275K sold.

Virtu Financial first reported a position in CNCE in Q1 2019 and held it in 4 quarters. The position peaked at $275K in Q2 2022. 80 funds tracked by Wall St. Rank hold CNCE as of Q3 2022.

Virtu Financial reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Virtu Financial sold 65,416 Concert Pharmaceuticals, Inc. shares in Q3 2022, an estimated $275K.
Virtu Financial first reported a position in Concert Pharmaceuticals, Inc. in Q1 2019 and held it in 4 quarters.
Virtu Financial's Concert Pharmaceuticals, Inc. position peaked at $275K in Q2 2022.
80 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.